Injection site reactions, such as bleeding or pain, were common side effects of Zepbound. These reactions should go away on their own within a few days of injecting your Zepbound dose. But ...

In clinical trials, the most common adverse effect of this treatment was injection site reaction (ISR). This can occur in up to 49% of patients and usually presents as erythema, pruritus ...

Eli Lilly intervenes in lawsuit to defend FDA's shortage determination of tirzepatide injections, branded as Mounjaro and Zepbound. FDA allows compounding of tirzepatide injections until February ...

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, manufactured by Novo Nordisk. Reuters Eli Lilly said Wednesday that its obesity drug Zepbound ...

Is Lilly stock a buy? According to key opinion leaders, positive SURMOUNT-5 results, alongside Lilly’s business strategy, means Zepbound is set to overtake competitors.

The Ministry of Health announced Thursday that drug injection sites in locations including Toronto, Ottawa and Thunder Bay will all be given funding to switch from supervised consumption to ...

Following positive results from its SURMOUNT-5 trial, Eli Lilly’s Zepbound (tirzepatide) will surpass Novo Nordisk’s Weogvy (semaglutide) in the obesity treatment market, according to a ...

Lilly in August began sending cease-and-desist letters to telehealth companies, wellness centers and medical spas selling compounded versions of Zepbound and Mounjaro. The company has also filed ...

TORONTO — The Ontario government is protecting the safety of children and families while improving access to recovery and treatment services by approving the transition of nine drug injection sites ...

According to a GlobalData report, Zepbound's superior effectiveness and strategic market growth position it to potentially overtake Wegovy as the leading therapy for obesity. Since its debut ...

The operator of the only supervised injection site in Hamilton — which the province is forcing to close — has been approved to run a new kind of homelessness and addiction treatment centre.